Events and Presentations
Upcoming Events
No events are currently scheduled
Past Events
August 7, 2019
8:00 AM EDT
8:00 AM EDT
June 25, 2019
3:20 PM EDT
3:20 PM EDT
June 12, 2019
2:00 PM PDT
2:00 PM PDT
June 3, 2019
8:00 AM EDT
8:00 AM EDT
May 14, 2019
9:20 AM PDT
9:20 AM PDT
May 8, 2019
8:00 AM EDT
8:00 AM EDT
May 7, 2019
9:00 AM EDT
9:00 AM EDT
April 10, 2019
11:20 AM EDT
11:20 AM EDT
March 19, 2019
8:35 AM EDT
8:35 AM EDT
March 14, 2019
8:30 AM EDT
8:30 AM EDT
Corporate Presentation
Pipeline Program Detail
Scientific & Medical Meetings
|
June 1, 2019
|
Source
A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Subjects With Resected Solid Tumors and in Combination With Pembrolizumab in Subjects With Unresectable Solid Tumors (Keynote-603)
|
|
|
June 1, 2019
|
Source
A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Subjects With Resected Solid Tumors and in Combination With Pembrolizumab in Subjects With Unresectable Solid Tumors (Keynote-603)
|